Ufp Technologies (UFPT) Other Non-Current Liabilities (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Other Non-Current Liabilities came in at $1.7 million in Q2 2026, down 59.21% on a YoY basis from $4.2 million in Q2 2025, and down 3.46% quarter-over-quarter from $1.8 million in Q1 2026.
Analysis
Ufp Technologies (UFPT) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has reported Other Non-Current Liabilities for 16 consecutive years, with $1.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Liabilities fell 59.21% year-over-year to $1.7 million; the trailing twelve-month figure through Jun 2026 stood at $1.7 million (down 59.21% YoY), and the FY2025 full-year result was $3.5 million, down 68.37% from the prior year.
- Other Non-Current Liabilities retreated to $1.7 million in Q2 2026 per UFPT's latest filing, from $1.8 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $20.6 million in Q2 2022 and bottomed at $1.7 million in Q2 2026.
- Historically, Other Non-Current Liabilities has averaged $11.8 million across 5 years, with a median of $12.5 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Other Non-Current Liabilities jumped 1725.12% in 2022, then tumbled 80.03% in 2026.
- Over 5 years, Other Non-Current Liabilities stood at $18.2 million in 2022, then slipped by 16.68% to $15.2 million in 2023, then slipped by 26.59% to $11.1 million in 2024, then sank by 68.37% to $3.5 million in 2025, then plunged by 51.77% to $1.7 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $1.7 million, $1.8 million, and $3.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.70 Mn |
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 4.28 Mn |
| Jun 30, 2025 | 4.17 Mn |
| Mar 31, 2025 | 8.82 Mn |
| Dec 31, 2024 | 11.14 Mn |
| Sep 30, 2024 | 10.94 Mn |
| Jun 30, 2024 | 9.76 Mn |
| Mar 31, 2024 | 13.82 Mn |
| Dec 31, 2023 | 15.18 Mn |
| Sep 30, 2023 | 15.04 Mn |
| Jun 30, 2023 | 14.59 Mn |
| Mar 31, 2023 | 19.48 Mn |
| Dec 31, 2022 | 18.22 Mn |
| Sep 30, 2022 | 19.55 Mn |
| Jun 30, 2022 | 20.58 Mn |
| Mar 31, 2022 | 19.56 Mn |
| Dec 31, 2021 | 15.19 Mn |
| Sep 30, 2021 | 1.07 Mn |